Nivolumab activity in advanced refractory malignant peritoneal mesothelioma. Becker O, Beaulaton C, Masliah-Planchon J, Servois V, et al. Eur J Cancer 2021;144:386-388.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Becker O, Beaulaton C, Masliah-Planchon J, Servois V, et al. Nivolumab activity in advanced refractory malignant peritoneal mesothelioma. Eur J Cancer 2021;144:386-388.
PMID: 33358840